Psychological distress, understanding of cancer and illness uncertainty in patients with Cancer of Unknown Primary

Kamil Wolyniec , Jessica Sharp , Krista Fisher , Richard W Tothill
Psycho‐Oncology 31 ( 11) 1869 -1876

6
2022
Six-year experience of Australia’s first dedicated cancer of unknown primary clinic

Arielle van Mourik , Gina Tonkin-Hill , John O’Farrell , Shohei Waller
British Journal of Cancer 129 ( 2) 301 -308

3
2023
2
2023
Molecular and genomic characterisation of a panel of human anal cancer cell lines

Glen R Guerra , Joseph C Kong , Rosemary M Millen , Matthew Read
Cell death & disease 12 ( 11) 959 -959

4
2021
Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.

Bo Gao , Kristina Lindemann , Lyndal Anderson , Sian Fereday
Gynecologic Oncology 142 ( 3) 458 -464

10
2016
An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin

Richard W Tothill , Adam Kowalczyk , Danny Rischin , Alex Bousioutas
Cancer Research 65 ( 10) 4031 -4040

202
2005
25
2014
The oncogenic functionality of JAK2 and PD-L1 to Eu-Myc lymphoma

Gareth Peter Gregory , Marcus Lefebure , Stephen R Mattarollo , Ben P Martin
Lorne Cancer Conference 2014

2014
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy

Kelly Waldeck , Jessica Van Zuylekom , Carleen Cullinane , Twishi Gulati
Theranostics 13 ( 14) 4745 -4745

3
2023
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Richard W Tothill , Anna V Tinker , Joshy George , Robert Brown
Clinical Cancer Research 14 ( 16) 5198 -5208

1,418
2008
Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch , Elizabeth L Christie , Dariush Etemadmoghadam , Dale W Garsed
Nature 521 ( 7553) 489 -494

1,292
2015
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles

Aidan Flynn , Andrew D Pattison , Shiva Balachander , Emma Boehm
Research square rs. 3. rs -4410500

2024
The evolution of molecular management of carcinoma of unknown primary

Tharani Sivakumaran , Richard W Tothill , Linda R Mileshkin
Current Opinion in Oncology 36 ( 5) 456 -464

1
2024
Evaluating the Utility of 18F-FDG PET/CT in Cancer of Unknown Primary

Tharani Sivakumaran , Anthony Cardin , Jason Callahan , Hui-li Wong
Journal of Nuclear Medicine 65 ( 10) 1557 -1563

2024
Recent progress in molecular classification of phaeochromocytoma and paraganglioma

Emma Boehm , Anthony J Gill , Roderick Clifton Bligh , Richard W Tothill
Best Practice & Research Clinical Endocrinology & Metabolism 101939 -101939

2024
Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primary

Richard J Rebello , Atara Posner , Ruining Dong , Owen WJ Prall
medRxiv 2024.08. 09.24311642 -2024.08. 09.24311642

2024
Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)

Grace Kong , Emma Boehm , Owen Prall , William K Murray
Current Oncology Reports 25 ( 5) 465 -478

2023
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

Simon J. Hogg , Andrea Newbold , Stephin J. Vervoort , Leonie A. Cluse
Molecular Cancer Therapeutics 15 ( 9) 2030 -2041

38
2016